Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/10/26 16:05 | 4/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Van Tuyl Christopher | NC | O | GC | 2 | S | -200 | 24.88 | 0 | -8 | 183 | D | |||||||||||||||
4/10/26 16:03 | 4/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Gloria Melanie | NC | O | COO | 2 | S | -307 | 25.65 | 0 | -12 | 245 | D | |||||||||||||||
4/10/26 16:02 | 4/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NC | O | CTO | 2 | S | -303 | 25.03 | 0 | -12 | 254 | D | |||||||||||||||
4/3/26 16:33 | 4/1/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 2 | M.d | 5,675 | 14.82 | 0 | 383 | 20 | D | |||||||||||||||
4/3/26 16:33 | 4/2/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 2 | S.d | -5,675 | 14.82 | 0 | -383 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |